Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microfluidic tissue model for live cell screening.

Philip J Lee1, Terry A Gaige, Navid Ghorashian

  • 1CellASIC Corporation, 2551 Merced St., San Leandro, California 94577, USA. pjlee@cellasic.com

Biotechnology Progress
|June 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skin and Soft Tissue Actinomycosis in Children and Adolescents.

The Pediatric infectious disease journal·2024
Same author

SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.

Molecular cancer therapeutics·2021
Same author

High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model.

ACS chemical neuroscience·2018
Same author

A multi-trap microfluidic chip enabling longitudinal studies of nerve regeneration in Caenorhabditis elegans.

Scientific reports·2017
Same author

Universal signal generator for dynamic cell stimulation.

Lab on a chip·2017
Same author

Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model.

Nature communications·2016
Same journal

Advanced glucose control strategies leveraging Raman spectroscopy for optimized mammalian cell culture manufacturing.

Biotechnology progress·2026
Same journal

Mechanistic deconvolution of BSA size variants by constrained Raman pseudo-Voigt hard modeling during anion-exchange chromatography.

Biotechnology progress·2026
Same journal

Status and future of recombinant adeno-associated virus vector manufacturing.

Biotechnology progress·2026
Same journal

Multifaceted algae as an ingredient in alternative meat formulations.

Biotechnology progress·2026
Same journal

In-line Raman spectroscopy real-time glucose prediction method for commercial pneumococcal vaccine drug substance fermentation manufacturing process control.

Biotechnology progress·2026
Same journal

Prolonged autophagy induction correlates with host cell protein reduction in CHO cell culture.

Biotechnology progress·2026
See all related articles

This study introduces a microfluidic platform for advanced cell culture, mimicking human microcirculation. The system enables high-throughput analysis of drug toxicity in tumor-like cell models.

Area of Science:

  • Biotechnology
  • Cell Biology
  • Microfluidics

Background:

  • Physiologic microcirculation is complex and difficult to replicate in vitro.
  • Existing cell culture methods lack the complexity to model solid tumor microenvironments.
  • High-throughput analysis of cellular responses to drugs is crucial for drug discovery.

Purpose of the Study:

  • To develop a novel microfluidic platform that mimics physiologic microcirculation for multiplexed tissue-like cell culture.
  • To enable high-throughput analysis of cellular responses, including drug toxicity.
  • To provide a more physiologically relevant model for cancer cell studies.

Main Methods:

  • Fabrication of a microfluidic chip with culture pockets, artificial endothelial barriers, and nutrient channels.

Related Experiment Videos

  • Culture of cancer cells (HeLa) in a solid tumor-like morphology under continuous flow.
  • Exposure of cells to the anti-cancer drug paclitaxel.
  • Analysis of drug toxicity using fluorescence microscopy and flow-through biochemistry.
  • Comparison with traditional 384-well plate culture methods.

    • Main Results:

    • The microfluidic platform successfully maintained cancer cells in a solid tumor-like morphology for over 1 week.
    • Continuous flow of nutrients supported high cell density.
    • The platform enabled multiplexed, high-throughput analysis of drug toxicity.
    • Results for paclitaxel toxicity in HeLa cells were comparable to conventional methods, demonstrating platform validity.

    Conclusions:

    • The developed microfluidic platform effectively replicates aspects of the physiologic microcirculation for advanced cell culture.
    • This technology offers a powerful tool for high-throughput drug screening and toxicological studies.
    • The platform provides a more predictive in vitro model for cancer research and drug development.